--- title: "Penghua SSE Science and Technology Innovation Board 200 ETF closed in the green today, with weighty sectors such as chemicals and electronics leading the gains" type: "News" locale: "en" url: "https://longbridge.com/en/news/281855828.md" description: "The Penghua SSE Science and Technology Innovation Board 200 ETF closed in the green today, with the chemical and electronics sectors leading the gains. The pharmaceutical and biotechnology sectors continue to show strength, and innovative drugs are entering a data catalyst period. The situation in the Middle East has raised concerns about resources, leading to panic buying in the domestic helium market. It is expected that SABIC will be affected by natural gas issues, resulting in a production halt impacting 25-30% of capacity, which will initiate price increases for high-end resins. Looking ahead, the SSE Science and Technology Innovation Board 200 is expected to experience short-term fluctuations and corrections, with the mid-term index center likely to shift upward. As of April 7, 2026, the SSE STAR 200 Index has risen by 0.35%, and the Penghua SSE Science and Technology Innovation Board 200 ETF has increased by 0.13%" datetime: "2026-04-07T09:04:13.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/281855828.md) - [en](https://longbridge.com/en/news/281855828.md) - [zh-HK](https://longbridge.com/zh-HK/news/281855828.md) --- # Penghua SSE Science and Technology Innovation Board 200 ETF closed in the green today, with weighty sectors such as chemicals and electronics leading the gains Today, sectors such as chemicals and electronics are leading the gains, while pharmaceuticals and biotechnology continue to show strength. On the news front, innovative drugs are entering a period of intensive data catalysis, with major academic conferences such as AACR (April 17–April 22) and ASCO (May 29–June 2) approaching. In addition, due to resource concerns triggered by the situation in the Middle East, there has been a noticeable panic buying in the domestic helium market, currently priced around 760 yuan (per cubic meter), which has doubled compared to usual prices. Meanwhile, the ongoing war in the Middle East has raised raw material costs, and SABIC's Saudi plant producing PPO monomers has halted production due to natural gas issues, expected to affect 25-30% of capacity, prompting SABIC to raise prices for high-end resins. Institutions point out that looking ahead, the Science and Technology Innovation 200 index may primarily experience a period of oscillation and repair in the short term, with the index center expected to gradually rise in the medium term. The short-term trend of the index still depends on whether a ceasefire agreement between the U.S. and Iran is reached and whether the Strait of Hormuz will be opened. In the medium term, if external disturbances ease marginally and industrial catalysts continue to materialize, the Science and Technology Innovation 200 index is expected to achieve an upward shift in its center. As of April 7, 2026, 15:00, the Shanghai Stock Exchange Science and Technology Innovation 200 Index (000699) rose by 0.35%, with constituent stock YK Bio rising by 9.28%, Dongwei Technology rising by 8.68%, Chenghe Technology rising by 8.07%, Huiyu Pharmaceutical rising by 7.48%, and Zhuoyue New Energy rising by 6.57%. The Science and Technology Innovation 200 ETF Penghua (588240) rose by 0.13%, with the latest price reported at 1.52 yuan. The Science and Technology Innovation 200 ETF Penghua closely tracks the Shanghai Stock Exchange Science and Technology Innovation 200 Index, which selects 200 securities with smaller market capitalization and better liquidity from the Shanghai Stock Exchange Science and Technology Innovation Board as samples. The Shanghai Stock Exchange Science and Technology Innovation 200 Index, along with the Shanghai Stock Exchange Science and Technology Innovation 50 Index and the Shanghai Stock Exchange Science and Technology Innovation 100 Index, constitutes the Shanghai Stock Exchange Science and Technology Innovation Board scale index series, reflecting the overall performance of securities of listed companies on the Science and Technology Innovation Board across different market capitalization scales. Data shows that as of March 31, 2026, the top ten weighted stocks in the Shanghai Stock Exchange Science and Technology Innovation 200 Index (000699) are Changguang Huaxin, Tengjing Technology, Juguang Technology, Dekeli, Jingzhida, Youkede, Jieput, Jiayuan Technology, Juhe Materials, and Weice Technology, with the top ten weighted stocks accounting for a total of 16.73%. The Science and Technology Innovation 200 ETF Penghua (588240) has off-exchange connections (A: 023926; C: 023927) ### Related Stocks - [516930.CN](https://longbridge.com/en/quote/516930.CN.md) - [588240.CN](https://longbridge.com/en/quote/588240.CN.md) - [588130.CN](https://longbridge.com/en/quote/588130.CN.md) - [159992.CN](https://longbridge.com/en/quote/159992.CN.md) - [512290.CN](https://longbridge.com/en/quote/512290.CN.md) - [588860.CN](https://longbridge.com/en/quote/588860.CN.md) - [159837.CN](https://longbridge.com/en/quote/159837.CN.md) - [512010.CN](https://longbridge.com/en/quote/512010.CN.md) - [159849.CN](https://longbridge.com/en/quote/159849.CN.md) - [560600.CN](https://longbridge.com/en/quote/560600.CN.md) - [516500.CN](https://longbridge.com/en/quote/516500.CN.md) - [510660.CN](https://longbridge.com/en/quote/510660.CN.md) - [588250.CN](https://longbridge.com/en/quote/588250.CN.md) - [159859.CN](https://longbridge.com/en/quote/159859.CN.md) - [000699.CN](https://longbridge.com/en/quote/000699.CN.md) - [516820.CN](https://longbridge.com/en/quote/516820.CN.md) ## Related News & Research - [Analyst Reiterates Buy on Microbix, Citing Temporary China Slowdown and Growing Diversified Demand](https://longbridge.com/en/news/286665358.md) - [Ab&B Bio-Tech Starts Early-Stage Trials for High-Yield RSV Vaccine as Trading Remains Suspended](https://longbridge.com/en/news/286268861.md) - [HBM Holdings Says Director Probed by CSRC, Sees No Impact on Operations](https://longbridge.com/en/news/286197909.md) - [Everest Medicines Director and Major Shareholder Raises Stake in Company](https://longbridge.com/en/news/286481551.md) - [20:03 ETHarbour BioMed Announces Promising Preclinical Data for LET003, Its First AI-Enabled Drug Candidate](https://longbridge.com/en/news/286688082.md)